Carolyn Fritz
Angel Investor · at Lewis & Clark Capital
Carolyn Fritz is a Series A investor at Lewis & Clark Capital focused on Biotechnology and Pharmaceutical. Ms. Fritz is currently Chairman of the Board of the synthetic biology company, DMC Biotechnologies; a board member of the microfibrillated cellulose company, CelluComp Ltd. and a Strategic Advisor to the phytochemical AI company, Brightseed. Prior to this, Ms. Fritz successfully built four biotechnology businesses. From 2004 - 2014, she builtthe synthetic biology company, Allylix from a start-up, raising $34 million in VC funding, developing and commercializing flavor & fragrances and insect repellents to a successful sale of company. From 1999 to 2004, at Dow Chemical, she built a renewable epoxy coating and soy polyol business and a biopharmaceutical contract manufacturing. From 1993 to 1999, at Cargill, she built an ag biotechnology/food technology business that developed and commercialized new functional canola oils for food and industrial markets. Ms. Fritz has her M.B.A from the Wharton School, University of Pennsylvania, her M.S. from The George Washington University and her B.S. in Mechanical Engineering from Iowa State University.
- Total investments:
- 2
- Last investment:
- Lead investor:
- 50%
Last updated:
For AI agents: llms.txt
Industries Carolyn Fritz invests in
Stages Carolyn Fritz invests in
Countries Carolyn Fritz invests in
Contacts
| Type | Contact | Validation |
|---|---|---|
| Work email | ||
| Personal email | ||
| Work phone | ||
| Personal phone | ||
| Socials |
Investment Focus
Industry
- Biotechnology 2 (100%)
- Pharmaceutical 2 (100%)
- Biofuel 1 (50%)
- Medical 1 (50%)
- Agriculture 1 (50%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Matterworks is a biotech startup that combines metabolomics with AI to simulate the metabolic environment. The startup is enabling real-time insights into cellular biology to accelerate therapeutic research, development, and manufacturing with an AI-driven cloud platform for metabolomics.Matterworks was founded by Mimoun Cadosch Delmar and JackGeremia in 2019. | Series A / Jun 03, 2025 | ||
| Allylix, Inc., an early stage biotechnology company, develops terpene products and their derivatives for the flavor and fragrance, food ingredient, pharmaceutical, agricultural, and biofuel markets. Its products comprise nootkatone, which is a grapefruit flavor that is used in fruit juices and citrus flavored sodas. The company also developssesquiterpenes that are part of aroma chemical segment of the flavor and fragrance market; and production platforms for pharmaceutical, nutraceutical, and agricultural markets. Allylix, Inc. was founded in 2002 and is based in San Diego, California with research and development laboratories in Lexington, Kentucky. | $1.5M / Series A / Aug 30, 2005 |
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Featured in Investor Lists
Recommended lists
FAQ
What does Carolyn Fritz invest in?
Carolyn Fritz invests primarily in Biotechnology, Pharmaceutical and Biofuel startups, most often at Series A stage. Most of the 2 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Carolyn Fritz?
Public channels for Carolyn Fritz include LinkedIn. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
When did Carolyn Fritz last invest?
The most recent investment recorded for Carolyn Fritz closed in Jun 2025. Shizune tracks 2 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
